Modification of daunorubicin‐GnRH‐III bioconjugates with oligoethylene glycol derivatives to improve solubility and bioavailability for targeted cancer chemotherapy

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0282|104|3|167-177

ISSN: 0006-3525

Source: BIOPOLYMERS, Vol.104, Iss.3, 2015-05, pp. : 167-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content